文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤免疫逃逸全球分布与研究前沿的文献计量学及可视化分析

Bibliometric and visualized analysis of global distribution and research frontiers in tumor immune escape.

作者信息

Zhang Chaihong, Chen Lihong

机构信息

Department of Obstetrics and Gynecology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.

出版信息

Front Immunol. 2025 Jun 5;16:1586120. doi: 10.3389/fimmu.2025.1586120. eCollection 2025.


DOI:10.3389/fimmu.2025.1586120
PMID:40539064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12176767/
Abstract

BACKGROUND: Tumor cells employ various mechanisms to evade detection and attack by the immune system, a phenomenon known as tumor immune escape, which represents a significant target for immunotherapy. Both primary and secondary immune escape mechanisms pose substantial challenges that hinder the efficacy of immunotherapy. This study aims to systematically examine the knowledge structure, hotspot frontiers, emerging trends, and future directions in the field of tumor immune escape through the application of bibliometric methods and knowledge mapping analysis. METHODS: A comprehensive search of the Web of Science Core Collection (WoSCC) was conducted for publications pertaining to tumor immune escape from January 1, 2015, to November 30, 2024. The annual publication data retrieved from the WoSCC were analyzed utilizing Microsoft Office Excel 2019. Furthermore, bibliometric analysis and visualization were executed using VOSviewer, Biblioshiny, and CiteSpace. RESULTS: This study encompassed a total of 11,128 articles published across 1,612 journals, authored by 71,684 individuals affiliated with 9,254 institutions in 121 countries. The United States, China, and Germany emerged as the leading contributors to this field, collectively accounting for 79.99% of all publications. Notable international collaboration was observed between the United States and China. Frontiers in Immunology, Nature Communications, the Journal for ImmunoTherapy of Cancer, and Nature were identified as the four most influential journals in tumor immune escape research. Zhang Wei was noted for the highest publication output, while Freeman Gordon J achieved the highest citation rate. Fudan University was recognized as the most productive institution, whereas Harvard Medical School was acknowledged as the most cited institution. Current hotspot frontiers in tumor immune escape research include immunotherapy, the tumor microenvironment, PD-L1, and PD-1. Additionally, emerging frontiers in recent years encompass immune checkpoint inhibitors, immune infiltration, natural killer cells, extracellular vesicles, immunogenic cell death, metabolism, ferroptosis, melanoma, lung adenocarcinoma, and prognosis. CONCLUSION: A comprehensive investigation into the mechanisms of tumor immune escape is essential for overcoming the existing challenges in immunotherapy. This study systematically analyzes the current state, research frontiers, and future directions, identifying the most prolific and highly cited documents, journals, authors, institutions, and countries in the field of tumor immune escape.

摘要

背景:肿瘤细胞采用多种机制来逃避免疫系统的检测和攻击,这种现象被称为肿瘤免疫逃逸,它是免疫治疗的一个重要靶点。原发性和继发性免疫逃逸机制都带来了巨大挑战,阻碍了免疫治疗的疗效。本研究旨在通过应用文献计量学方法和知识图谱分析,系统地考察肿瘤免疫逃逸领域的知识结构、热点前沿、新兴趋势和未来方向。 方法:对科学网核心合集(WoSCC)进行全面检索,查找2015年1月1日至2024年11月30日期间与肿瘤免疫逃逸相关的出版物。利用Microsoft Office Excel 2019对从WoSCC检索到的年度出版数据进行分析。此外,使用VOSviewer、Biblioshiny和CiteSpace进行文献计量分析和可视化。 结果:本研究共纳入11128篇发表在1612种期刊上的文章,作者来自121个国家的9254个机构,共71684人。美国、中国和德国是该领域的主要贡献者,合计占所有出版物的79.99%。观察到美国和中国之间有显著的国际合作。《免疫学前沿》《自然通讯》《癌症免疫治疗杂志》和《自然》被确定为肿瘤免疫逃逸研究中最具影响力的四种期刊。张伟的发文量最高,而弗里曼·戈登·J的被引率最高。复旦大学被认为是发文量最多的机构,而哈佛医学院被认为是被引次数最多的机构。肿瘤免疫逃逸研究当前的热点前沿包括免疫治疗、肿瘤微环境、程序性死亡配体1(PD-L1)和程序性死亡受体1(PD-1)。此外,近年来的新兴前沿包括免疫检查点抑制剂、免疫浸润、自然杀伤细胞、细胞外囊泡、免疫原性细胞死亡、代谢、铁死亡、黑色素瘤、肺腺癌和预后。 结论:全面研究肿瘤免疫逃逸机制对于克服免疫治疗中现存的挑战至关重要。本研究系统地分析了当前状况、研究前沿和未来方向,确定了肿瘤免疫逃逸领域中发文最多和被引次数最多的文献、期刊、作者、机构和国家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/f7b310dc8a9b/fimmu-16-1586120-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/525b395a7f6c/fimmu-16-1586120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/d485eb882af8/fimmu-16-1586120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/ffc520b1123b/fimmu-16-1586120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/60017af79a7e/fimmu-16-1586120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/bd5460cb9096/fimmu-16-1586120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/90ce6c01b6a3/fimmu-16-1586120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/fd3020e76088/fimmu-16-1586120-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/f7b310dc8a9b/fimmu-16-1586120-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/525b395a7f6c/fimmu-16-1586120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/d485eb882af8/fimmu-16-1586120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/ffc520b1123b/fimmu-16-1586120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/60017af79a7e/fimmu-16-1586120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/bd5460cb9096/fimmu-16-1586120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/90ce6c01b6a3/fimmu-16-1586120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/fd3020e76088/fimmu-16-1586120-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51ba/12176767/f7b310dc8a9b/fimmu-16-1586120-g008.jpg

相似文献

[1]
Bibliometric and visualized analysis of global distribution and research frontiers in tumor immune escape.

Front Immunol. 2025-6-5

[2]
Driving innovations in cancer research through spatial metabolomics: a bibliometric review of trends and hotspot.

Front Immunol. 2025-6-10

[3]
Research trends on lactate in cancer: a bibliometric analysis and comprehensive review (2015-2024).

Front Immunol. 2025-5-9

[4]
A bibliometric analysis of research trends in mesenchymal stem cell therapy for neonatal bronchopulmonary dysplasia: 2004-2024.

Front Pediatr. 2025-6-3

[5]
Bibliometric analysis of immunotherapy in treatment of uveal melanoma.

Medicine (Baltimore). 2025-6-20

[6]
A Bibliometric Analysis and Visualization of Research Trends and Hotspots in Actinic Keratosis Based on Web of Science.

Clin Cosmet Investig Dermatol. 2025-6-19

[7]
Emerging trends of the tumor microenvironment in peritoneal malignancies (2010-2024): a visualization analysis.

Front Oncol. 2025-6-4

[8]
Comprehensive Global Analysis of Future Trends in Artificial Intelligence-Assisted Veterinary Medicine.

Vet Med Sci. 2025-5

[9]
Mapping current research status and emerging frontiers of lipidomics: a comprehensive data-mining-based study.

Metabolomics. 2025-6-22

[10]
Tracing inflammasomes in Alzheimer's: insights from bibliometric analysis.

Front Neurol. 2025-6-5

本文引用的文献

[1]
Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review.

Cancers (Basel). 2025-2-1

[2]
Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma.

Cancer Cell. 2025-2-10

[3]
Drivers of centrosome abnormalities: Senescence progression and tumor immune escape.

Semin Cancer Biol. 2025-5

[4]
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.

Cancer. 2025-2-15

[5]
Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8/CXCR2 signaling.

Mol Ther. 2025-4-2

[6]
lncRNA ENST000000454471 promotes lung adenocarcinoma progression and tumor immune escape: Protein structure and biological functions of histone deacetylase 8.

Int J Biol Macromol. 2025-4

[7]
IL-8 contributes to functional diversity of tumor-infiltrating neutrophils: A new target for cancer immunotherapy.

Dev Cell. 2025-2-3

[8]
Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression.

Genes Dis. 2024-2-2

[9]
A Distinguished Roadmap of Fibroblast Senescence in Predicting Immunotherapy Response and Prognosis Across Human Cancers.

Adv Sci (Weinh). 2025-2

[10]
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy.

Cancer Immunol Immunother. 2024-11-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索